A detailed history of First Capital Advisors Group, Llc. transactions in Boston Scientific Corp stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 5,473 shares of BSX stock, worth $462,413. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,473
Previous 5,473 -0.0%
Holding current value
$462,413
Previous $273,000 8.42%
% of portfolio
0.16%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $541 - $600
12 Added 0.22%
5,473 $273,000
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $158 - $188
4 Added 0.07%
5,461 $252,000
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $7,048 - $21,054
-192 Reduced 3.4%
5,457 $211,000
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $199,070 - $266,067
5,649 New
5,649 $211,000
Q2 2018

Jul 30, 2018

SELL
$26.84 - $34.32 $536 - $686
-20 Closed
0 $0
Q1 2018

Apr 11, 2018

BUY
$25.2 - $28.54 $504 - $570
20 New
20 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track First Capital Advisors Group, Llc. Portfolio

Follow First Capital Advisors Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.